Elicio Therapeutics (ELTX) Asset Utilization Ratio (2021 - 2023)

Elicio Therapeutics has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.02 in Q1 2023.

• For the quarter ending Q1 2023, Asset Utilization Ratio fell 93.74% year-over-year to 0.02; the trailing twelve-month figure through Mar 2023 stood at 0.02 (down 93.74% YoY), and the FY2022 full-year result was 0.04, down 89.9% from the prior year.
• Asset Utilization Ratio for Q1 2023 stood at 0.02, down from 0.05 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.42 in Q3 2022, with the low at 0.0 in Q2 2021.
• Historically, Asset Utilization Ratio has averaged 0.16 across 3 years, with a median of 0.05 in 2022.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 34066.99% — and 2023, when it plunged 93.74%.
• Elicio Therapeutics' Asset Utilization Ratio stood at 0.27 in 2021, then plunged by 79.43% to 0.05 in 2022, then tumbled by 63.01% to 0.02 in 2023.
• The last three Asset Utilization Ratio figures came in at 0.02 (Q1 2023), 0.05 (Q4 2022), and 0.42 (Q3 2022), per Business Quant data.